Mondor's disease: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(3 intermediate revisions by the same user not shown)
Line 15: Line 15:
}}
}}
{{SI}}
{{SI}}
{{CMG}}
{{CMG}} {{AE}} {{S.M}}


==Overview==
==Overview==
Line 26: Line 26:
==Differentiating Mondor's Disease from other Diseases==
==Differentiating Mondor's Disease from other Diseases==
Mondor's disease must be differentiated from other diseases that cause [[breast pain]] and [[swelling]].
Mondor's disease must be differentiated from other diseases that cause [[breast pain]] and [[swelling]].
<small>'''ABBREVIATIONS'''<br>LAP=Lymphadenopathy, HRT=Hormonal replacement therapy, FNA=Fine needle aspiration, DCIS=Ductal carcinoma in-situ</small>
<small>'''ABBREVIATIONS'''<br>LAP=Lymphadenopathy, HRT=Hormonal replacement therapy, FNA=Fine needle aspiration, DCIS=Ductal carcinoma in-situ</small>


Line 51: Line 52:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LAP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LAP
|-
|-
! align="center" style="background:#DCDCDC;" |[[Fibroadenoma]]<ref name="PintoAguiar2014">{{cite journal|last1=Pinto|first1=Joana|last2=Aguiar|first2=Ana Teresa|last3=Duarte|first3=Hálio|last4=Vilaverde|first4=Filipa|last5=Rodrigues|first5=Ângelo|last6=Krug|first6=José Luís|title=Simple and Complex Fibroadenomas|journal=Journal of Ultrasound in Medicine|volume=33|issue=3|year=2014|pages=415–419|issn=02784297|doi=10.7863/ultra.33.3.415}}</ref>
! align="center" style="background:#DCDCDC;" |[[Fibroadenoma]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]]
* [[Benign]]
Line 78: Line 79:
* [[Biopsy]]
* [[Biopsy]]
|-
|-
! align="center" style="background:#DCDCDC;" |[[Breast]] [[cyst]]<ref name="pmid16900392">{{cite journal| author=Courtillot C, Plu-Bureau G, Binart N, Balleyguier C, Sigal-Zafrani B, Goffin V et al.| title=Benign breast diseases. | journal=J Mammary Gland Biol Neoplasia | year= 2005 | volume= 10 | issue= 4 | pages= 325-35 | pmid=16900392 | doi=10.1007/s10911-006-9006-4 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16900392  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Breast]] [[cyst]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]]
* [[Benign]]
Line 109: Line 110:
* [[Fine needle aspiration]] ([[FNA]])  
* [[Fine needle aspiration]] ([[FNA]])  
|-
|-
! align="center" style="background:#DCDCDC;" |Fibrocystic change<ref name="pmid10693180">{{cite journal| author=Templeman C, Hertweck SP| title=Breast disorders in the pediatric and adolescent patient. | journal=Obstet Gynecol Clin North Am | year= 2000 | volume= 27 | issue= 1 | pages= 19-34 | pmid=10693180 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10693180  }}</ref>
! align="center" style="background:#DCDCDC;" |Fibrocystic change
| align="left" style="background:#F5F5F5;" left" |
| align="left" style="background:#F5F5F5;" left" |
* [[Benign]]
* [[Benign]]
Line 136: Line 137:
* [[Mammography]] (it is not recommended for adolescents)
* [[Mammography]] (it is not recommended for adolescents)
|-
|-
! align="center" style="background:#DCDCDC;" |[[Galactocele]]<ref name="pmid24327995">{{cite journal| author=Yu JH, Kim MJ, Cho H, Liu HJ, Han SJ, Ahn TG| title=Breast diseases during pregnancy and lactation. | journal=Obstet Gynecol Sci | year= 2013 | volume= 56 | issue= 3 | pages= 143-59 | pmid=24327995 | doi=10.5468/ogs.2013.56.3.143 | pmc=3784111 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24327995  }}</ref><ref name="pmid18180221">{{cite journal| author=Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de las Heras P et al.| title=Radiologic evaluation of breast disorders related to pregnancy and lactation. | journal=Radiographics | year= 2007 | volume= 27 Suppl 1 | issue=  | pages= S101-24 | pmid=18180221 | doi=10.1148/rg.27si075505 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18180221  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Galactocele]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]]
* [[Benign]]
Line 162: Line 163:
* [[Mammography]]
* [[Mammography]]
|-
|-
! align="center" style="background:#DCDCDC;" |[[Cysts]] of [[Glands of Montgomery|montgomery]]<ref name="pmid17174833">{{cite journal| author=De Silva NK, Brandt ML| title=Disorders of the breast in children and adolescents, Part 2: breast masses. | journal=J Pediatr Adolesc Gynecol | year= 2006 | volume= 19 | issue= 6 | pages= 415-8 | pmid=17174833 | doi=10.1016/j.jpag.2006.09.002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17174833  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Cysts]] of [[Glands of Montgomery|montgomery]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]]
* [[Benign]]
Line 186: Line 187:
* [[Ultrasound]]
* [[Ultrasound]]
|-
|-
! align="center" style="background:#DCDCDC;" |[[Hemangioma|Hamartoma]]<ref name="pmid12461066">{{cite journal| author=Tse GM, Law BK, Ma TK, Chan AB, Pang LM, Chu WC et al.| title=Hamartoma of the breast: a clinicopathological review. | journal=J Clin Pathol | year= 2002 | volume= 55 | issue= 12 | pages= 951-4 | pmid=12461066 | doi= | pmc=1769817 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12461066  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Hemangioma|Hamartoma]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]]
* [[Benign]]
Line 213: Line 214:
* [[Mammography]]
* [[Mammography]]
|-
|-
! align="center" style="background:#DCDCDC;" |[[Breast abscess]]<ref name="pmid26095437">{{cite journal| author=D'Alfonso TM, Ginter PS, Shin SJ| title=A Review of Inflammatory Processes of the Breast with a Focus on Diagnosis in Core Biopsy Samples. | journal=J Pathol Transl Med | year= 2015 | volume= 49 | issue= 4 | pages= 279-87 | pmid=26095437 | doi=10.4132/jptm.2015.06.11 | pmc=4508565 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26095437  }}</ref><ref name="pmid17639835">{{cite journal| author=Dixon JM| title=Breast abscess. | journal=Br J Hosp Med (Lond) | year= 2007 | volume= 68 | issue= 6 | pages= 315-20 | pmid=17639835 | doi=10.12968/hmed.2007.68.6.23574 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17639835  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Breast abscess]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]]
* [[Benign]]
Line 238: Line 239:
* [[Ultrasound]]
* [[Ultrasound]]
|-
|-
! align="center" style="background:#DCDCDC;" |[[Mastitis]]<ref name="pmid8696751">{{cite journal| author=Dixon JM, Ravisekar O, Chetty U, Anderson TJ| title=Periductal mastitis and duct ectasia: different conditions with different aetiologies. | journal=Br J Surg | year= 1996 | volume= 83 | issue= 6 | pages= 820-2 | pmid=8696751 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8696751  }}</ref><ref name="pmid17267864">{{cite journal| author=Committee on Health Care for Underserved Women, American College of Obstetricians and Gynecologists| title=ACOG Committee Opinion No. 361: Breastfeeding: maternal and infant aspects. | journal=Obstet Gynecol | year= 2007 | volume= 109 | issue= 2 Pt 1 | pages= 479-80 | pmid=17267864 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17267864  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Mastitis]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]]
* [[Benign]]
Line 278: Line 279:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis
|-
|-
! align="center" style="background:#DCDCDC;" |[[Breast carcinoma]]<ref name="pmid29313949">{{cite journal |vauthors=Siegel RL, Miller KD, Jemal A |title=Cancer statistics, 2018 |journal=CA Cancer J Clin |volume=68 |issue=1 |pages=7–30 |date=January 2018 |pmid=29313949 |doi=10.3322/caac.21442 |url=}}</ref><ref name="pmid16175185">{{cite journal |vauthors=Li CI, Uribe DJ, Daling JR |title=Clinical characteristics of different histologic types of breast cancer |journal=Br. J. Cancer |volume=93 |issue=9 |pages=1046–52 |date=October 2005 |pmid=16175185 |pmc=2361680 |doi=10.1038/sj.bjc.6602787 |url=}}</ref><ref name="pmid19764994">{{cite journal |vauthors=Parise CA, Bauer KR, Brown MM, Caggiano V |title=Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004 |journal=Breast J |volume=15 |issue=6 |pages=593–602 |date=2009 |pmid=19764994 |doi=10.1111/j.1524-4741.2009.00822.x |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Breast carcinoma]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Malignant]]
* [[Malignant]]
Line 313: Line 314:
* [[Mammography]]
* [[Mammography]]
|-
|-
! align="center" style="background:#DCDCDC;" |[[Ductal carcinoma in situ]] ([[DCIS]])<ref name="pmid20071685">{{cite journal |vauthors=Virnig BA, Tuttle TM, Shamliyan T, Kane RL |title=Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes |journal=J. Natl. Cancer Inst. |volume=102 |issue=3 |pages=170–8 |date=February 2010 |pmid=20071685 |doi=10.1093/jnci/djp482 |url=}}</ref><ref name="pmid19001605">{{cite journal |vauthors=Brinton LA, Sherman ME, Carreon JD, Anderson WF |title=Recent trends in breast cancer among younger women in the United States |journal=J. Natl. Cancer Inst. |volume=100 |issue=22 |pages=1643–8 |date=November 2008 |pmid=19001605 |pmc=2720764 |doi=10.1093/jnci/djn344 |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Ductal carcinoma in situ]] ([[DCIS]])
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Malignant]]
* [[Malignant]]
Line 338: Line 339:
* [[Mammography]]
* [[Mammography]]
|-
|-
! align="center" style="background:#DCDCDC;" |Microinvasive [[breast cancer]]<ref name="pmid23791403">{{cite journal |vauthors=Sue GR, Lannin DR, Killelea B, Chagpar AB |title=Predictors of microinvasion and its prognostic role in ductal carcinoma in situ |journal=Am. J. Surg. |volume=206 |issue=4 |pages=478–81 |date=October 2013 |pmid=23791403 |doi=10.1016/j.amjsurg.2013.01.039 |url=}}</ref>
! align="center" style="background:#DCDCDC;" |Microinvasive [[breast cancer]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Malignant]]
* [[Malignant]]
Line 364: Line 365:
* [[Mammography]]
* [[Mammography]]
|-
|-
! align="center" style="background:#DCDCDC;" |[[Breast]] [[sarcoma]]<ref name="pmid22451578">{{cite journal |vauthors=Smith TB, Gilcrease MZ, Santiago L, Hunt KK, Yang WT |title=Imaging features of primary breast sarcoma |journal=AJR Am J Roentgenol |volume=198 |issue=4 |pages=W386–93 |date=April 2012 |pmid=22451578 |doi=10.2214/AJR.11.7341 |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Breast]] [[sarcoma]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Malignant]]
* [[Malignant]]
Line 388: Line 389:
* [[Mammography]]
* [[Mammography]]
|-
|-
! align="center" style="background:#DCDCDC;" |[[Phyllodes tumor]]<ref name="pmid10776873">{{cite journal |vauthors=Geisler DP, Boyle MJ, Malnar KF, McGee JM, Nolen MC, Fortner SM, Broughan TA |title=Phyllodes tumors of the breast: a review of 32 cases |journal=Am Surg |volume=66 |issue=4 |pages=360–6 |date=April 2000 |pmid=10776873 |doi= |url=}}</ref><ref name="pmid11013364">{{cite journal |vauthors=Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, Hunt KK |title=Primary treatment of cystosarcoma phyllodes of the breast |journal=Cancer |volume=89 |issue=7 |pages=1502–11 |date=October 2000 |pmid=11013364 |doi= |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Phyllodes tumor]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]] or
* [[Benign]] or
Line 421: Line 422:
* [[Mammography]]
* [[Mammography]]
|-
|-
! align="center" style="background:#DCDCDC;" |[[Lymphoma]]<ref name="pmid10375092">{{cite journal |vauthors=Brogi E, Harris NL |title=Lymphomas of the breast: pathology and clinical behavior |journal=Semin. Oncol. |volume=26 |issue=3 |pages=357–64 |date=June 1999 |pmid=10375092 |doi= |url=}}</ref><ref name="pmid10859001">{{cite journal |vauthors=Barişta I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozişik Y, Güler N, Güllü IH, Atahan IL, Firat D |title=Primary breast lymphomas--a retrospective analysis of twelve cases |journal=Acta Oncol |volume=39 |issue=2 |pages=135–9 |date=2000 |pmid=10859001 |doi= |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Lymphoma]]  
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Malignant]]
* [[Malignant]]
Line 447: Line 448:
* Core [[biopsy]]
* Core [[biopsy]]
|-
|-
! align="center" style="background:#DCDCDC;" |[[Duct ectasia]]<ref name="pmid6286199">{{cite journal |vauthors=Schwartz GF |title=Benign neoplasms and "inflammations" of the breast |journal=Clin Obstet Gynecol |volume=25 |issue=2 |pages=373–85 |date=June 1982 |pmid=6286199 |doi= |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Duct ectasia]]
| align="Left" style="background:#F5F5F5;" |
| align="Left" style="background:#F5F5F5;" |
* [[Benign]]
* [[Benign]]
Line 469: Line 470:
* [[Ultrasound]]
* [[Ultrasound]]
|-
|-
! align="center" style="background:#DCDCDC;" |Intraductal [[papilloma]]<ref name="pmid22878621">{{cite journal |vauthors=Wen X, Cheng W |title=Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors |journal=Ann. Surg. Oncol. |volume=20 |issue=1 |pages=94–101 |date=January 2013 |pmid=22878621 |doi=10.1245/s10434-012-2590-1 |url=}}</ref>
! align="center" style="background:#DCDCDC;" |Intraductal [[papilloma]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]]
* [[Benign]]
Line 494: Line 495:
* Core needle [[biopsy]]
* Core needle [[biopsy]]
|-
|-
! align="center" style="background:#DCDCDC;" |[[Lipoma]]<ref name="pmid16720843">{{cite journal |vauthors=Guray M, Sahin AA |title=Benign breast diseases: classification, diagnosis, and management |journal=Oncologist |volume=11 |issue=5 |pages=435–49 |date=May 2006 |pmid=16720843 |doi=10.1634/theoncologist.11-5-435 |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Lipoma]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]]
* [[Benign]]
Line 521: Line 522:
|
|
|-
|-
! align="center" style="background:#DCDCDC;" |[[Sclerosing adenosis]]<ref name="pmid2804888">{{cite journal| author=Jensen RA, Page DL, Dupont WD, Rogers LW| title=Invasive breast cancer risk in women with sclerosing adenosis. | journal=Cancer | year= 1989 | volume= 64 | issue= 10 | pages= 1977-83 | pmid=2804888 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2804888  }}</ref><ref name="pmid15100339">{{cite journal| author=Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N| title=Lower-category benign breast disease and the risk of invasive breast cancer. | journal=J Natl Cancer Inst | year= 2004 | volume= 96 | issue= 8 | pages= 616-20 | pmid=15100339 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15100339  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Sclerosing adenosis]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Small risk of [[malignancy]]
* Small risk of [[malignancy]]
Line 547: Line 548:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
|-
|-
| align="center" style="background:#DCDCDC;" |'''Pseudoangiomatous stromal hyperplasia<ref name="pmid20103437">{{cite journal| author=Celliers L, Wong DD, Bourke A| title=Pseudoangiomatous stromal hyperplasia: a study of the mammographic and sonographic features. | journal=Clin Radiol | year= 2010 | volume= 65 | issue= 2 | pages= 145-9 | pmid=20103437 | doi=10.1016/j.crad.2009.10.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20103437  }}</ref><ref name="pmid15454202">{{cite journal| author=Salvador R, Lirola JL, Domínguez R, López M, Risueño N| title=Pseudo-angiomatous stromal hyperplasia presenting as a breast mass: imaging findings in three patients. | journal=Breast | year= 2004 | volume= 13 | issue= 5 | pages= 431-5 | pmid=15454202 | doi=10.1016/j.breast.2003.10.011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15454202  }}</ref>'''
| align="center" style="background:#DCDCDC;" |'''Pseudoangiomatous stromal hyperplasia'''
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]]
* [[Benign]]
Line 574: Line 575:
* [[Mammography]]
* [[Mammography]]
|-
|-
| align="center" style="background:#DCDCDC;" |'''[[Mondor's disease]]<ref name="pmid11436415">{{cite journal| author=Becker L, McCurdy LI, Taves DH| title=Superficial thrombophlebitis of the breast (Mondor's disease). | journal=Can Assoc Radiol J | year= 2001 | volume= 52 | issue= 3 | pages= 193-5 | pmid=11436415 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11436415  }}</ref><ref name="pmid1562972">{{cite journal| author=Catania S, Zurrida S, Veronesi P, Galimberti V, Bono A, Pluchinotta A| title=Mondor's disease and breast cancer. | journal=Cancer | year= 1992 | volume= 69 | issue= 9 | pages= 2267-70 | pmid=1562972 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1562972  }}</ref>'''
| align="center" style="background:#DCDCDC;" |'''[[Mondor's disease]]'''
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]]
* [[Benign]]
Line 613: Line 614:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis
|-
|-
| align="center" style="background:#DCDCDC;" |'''[[Diabetic]] mastopathy<ref name="pmid11772912">{{cite journal| author=Kudva YC, Reynolds C, O'Brien T, Powell C, Oberg AL, Crotty TB| title="Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes. | journal=Diabetes Care | year= 2002 | volume= 25 | issue= 1 | pages= 121-6 | pmid=11772912 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11772912  }}</ref>'''
| align="center" style="background:#DCDCDC;" |'''[[Diabetic]] mastopathy'''
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]]
* [[Benign]]
Line 642: Line 643:
* Core needle [[biopsy]]
* Core needle [[biopsy]]
|-
|-
! align="center" style="background:#DCDCDC;" |[[Gynecomastia]]<ref name="pmid23397020">{{cite journal| author=Draghi F, Tarantino CC, Madonia L, Ferrozzi G| title=Ultrasonography of the male breast. | journal=J Ultrasound | year= 2011 | volume= 14 | issue= 3 | pages= 122-9 | pmid=23397020 | doi=10.1016/j.jus.2011.06.004 | pmc=3558246 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23397020  }}</ref><ref name="pmid17881754">{{cite journal| author=Braunstein GD| title=Clinical practice. Gynecomastia. | journal=N Engl J Med | year= 2007 | volume= 357 | issue= 12 | pages= 1229-37 | pmid=17881754 | doi=10.1056/NEJMcp070677 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17881754  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Gynecomastia]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]]
* [[Benign]]
Line 669: Line 670:
* [[Ultrasound]]
* [[Ultrasound]]
|-
|-
! align="center" style="background:#DCDCDC;" |[[Sarcoidosis]]<ref name="pmid11587103">{{cite journal| author=Lower EE, Hawkins HH, Baughman RP| title=Breast disease in sarcoidosis. | journal=Sarcoidosis Vasc Diffuse Lung Dis | year= 2001 | volume= 18 | issue= 3 | pages= 301-6 | pmid=11587103 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11587103  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Sarcoidosis]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]]
* [[Benign]]
Line 694: Line 695:
* [[Biopsy]]
* [[Biopsy]]
|-
|-
! align="center" style="background:#DCDCDC;" |[[Fat necrosis]]<ref name="pmid9423681">{{cite journal| author=Soo MS, Kornguth PJ, Hertzberg BS| title=Fat necrosis in the breast: sonographic features. | journal=Radiology | year= 1998 | volume= 206 | issue= 1 | pages= 261-9 | pmid=9423681 | doi=10.1148/radiology.206.1.9423681 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9423681  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Fat necrosis]]
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* [[Benign]]
* [[Benign]]
Line 721: Line 722:
* [[Ultrasound]]
* [[Ultrasound]]
|}
|}
</small>


==External links.==  
==External links.==  
Line 731: Line 734:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
<references />

Latest revision as of 16:56, 22 August 2021

Mondor's disease
ICD-10 I80.8 (ILDS I80.81)
ICD-9 451.89
DiseasesDB 32183
eMedicine derm/909 

WikiDoc Resources for Mondor's disease

Articles

Most recent articles on Mondor's disease

Most cited articles on Mondor's disease

Review articles on Mondor's disease

Articles on Mondor's disease in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mondor's disease

Images of Mondor's disease

Photos of Mondor's disease

Podcasts & MP3s on Mondor's disease

Videos on Mondor's disease

Evidence Based Medicine

Cochrane Collaboration on Mondor's disease

Bandolier on Mondor's disease

TRIP on Mondor's disease

Clinical Trials

Ongoing Trials on Mondor's disease at Clinical Trials.gov

Trial results on Mondor's disease

Clinical Trials on Mondor's disease at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mondor's disease

NICE Guidance on Mondor's disease

NHS PRODIGY Guidance

FDA on Mondor's disease

CDC on Mondor's disease

Books

Books on Mondor's disease

News

Mondor's disease in the news

Be alerted to news on Mondor's disease

News trends on Mondor's disease

Commentary

Blogs on Mondor's disease

Definitions

Definitions of Mondor's disease

Patient Resources / Community

Patient resources on Mondor's disease

Discussion groups on Mondor's disease

Patient Handouts on Mondor's disease

Directions to Hospitals Treating Mondor's disease

Risk calculators and risk factors for Mondor's disease

Healthcare Provider Resources

Symptoms of Mondor's disease

Causes & Risk Factors for Mondor's disease

Diagnostic studies for Mondor's disease

Treatment of Mondor's disease

Continuing Medical Education (CME)

CME Programs on Mondor's disease

International

Mondor's disease en Espanol

Mondor's disease en Francais

Business

Mondor's disease in the Marketplace

Patents on Mondor's disease

Experimental / Informatics

List of terms related to Mondor's disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Mondor's disease is a rare condition which involves thrombophlebitis of the superficial veins of the breast and anterior chest wall. It sometimes occurs in the arm or penis.

Historical Perspective

It is named after Henri Mondor (1885-1962), a surgeon in Paris, France who first described the disease in 1939.


Differentiating Mondor's Disease from other Diseases

Mondor's disease must be differentiated from other diseases that cause breast pain and swelling.

ABBREVIATIONS
LAP=Lymphadenopathy, HRT=Hormonal replacement therapy, FNA=Fine needle aspiration, DCIS=Ductal carcinoma in-situ

Diseases Benign or

Malignant

Clinical manifestation Paraclinical findings Gold standard diagnosis
Demography History Symptoms Signs Histopathology Imaging
Mass Mastalgia Nipple discharge Breast exam Skin changes LAP
Fibroadenoma + ±
  • Solitary
  • Well-defined
  • Mobile mass
Ultrasound:
  • Well-defined
  • Solid mass
Breast cyst
  • May resolve after aspiration
  • Further evaluation for unresolved masses
+ ±
  • Solitary
  • Cluster of small masses or an ill-defined mass
  • Smooth, firm, and frequently tender
  • Nonproliferative breast lesions
Ultrasound:
  • Simple cyst: Well circumscribed, posterior acoustic enhancement without internal echoes
  • Complicated cyst: Homogenous low-level internal echoes due to without solid components
  • Complex cyst: Thick walls greater than 0.5 mm with solid component
Fibrocystic change
  • Unknown prevalence among adolescents
  • >50% in women of reproductive age
+ + ±
  • Nonproliferative breast lesions
Ultrasound:
  • Small cysts in mammary zone
  • Fibroglandular tissue around the mass
Galactocele + ± ± Mammography:
  • Intermediate mass in absence of classic fat-fluid level

Ultrasound:

  • Complex mass
Cysts of montgomery
  • Most common in age of 10-20 years old
  • More than 80% resolve spontaneously
  • Drainage is essential in rare cases
+ ± ±
  • Asymptomatic subareolar mass
  • Drainage of clear to brownish fluid
± Ultrasound:
  • Single cystic lesion in retroareolar area
Hamartoma
  • Common in women older than 35 years old
± ± Mammography:
  • Well-described
  • Discrete, solid, and encapsulated lesion
Breast abscess
  • Complication of lactational mastitis in 14% of cases
  • Common among African-American women, heavy smokers , and obese patients
+ + + Ultrasound:
  • Fluid collection
Mastitis ± + ± + Breast parenchyma inflammation: Ultrasound:
  • Ill-defined area with hyperechogenicity with inflamed fat lobules
  • Skin thickening
Diseases Benign or
Malignant
Demography History Mass Mastalgia Nipple discharge Breast exam Skin changes LAP Histopathology Imaging Gold standard diagnosis
Breast carcinoma
  • Most common diagnosed cancer among women
  • Leading cause of cancer death in women 40-49 years old
+ ±
  • Hard
  • Immobile
  • Solitary
  • Irregular margin
± ± Mammography:

Ultrasound:

Ductal carcinoma in situ (DCIS) ± ±
  • May have normal physical exam
Mammography:
Microinvasive breast cancer
  • Rare
  • Commonly referred to DCIS with microinvasion
  • Average age 50-60 years old
+ ±
  • Solitary
  • Firm palpable mass
±
  • Associated with high grade DCIS
Mammography:
Breast sarcoma
  • Rare type, < 1% of all breast malignancies
  • Average age of between 45-50 years
+
  • Well-defined
  • Firm mass
± Mammography:
  • Noncalcified oval mass Indistinct margins
Phyllodes tumor ±
  • Smooth and multinodular
  • Well-defined
  • Firm mass
  • Mobile
  • Nonepithelial breast neoplasm with average size of 5 cm
Ultrasound:
  • Solid mass
  • Hypoechoic
  • Well-circumscribed

Mammography:

  • Smooth mass
  • Polylobulated mass
Lymphoma
  • Extremely rare ( 0.04%-0.5%)
  • Average age 55-60 years
+
  • Well-defined, firm mass
  • Multiple
± Mammography:
Duct ectasia
  • Usually resolve spontaneously
± ± ±
  • Usually asymptomatic
  • Distention of subareolar ducts
Ultrasound:
  • Dilated milk ducts
  • Fluid-filled ducts
Intraductal papilloma
  • Common in women between 35-55 years old
+ ± ±
  • Solitary or multiple lesion
  • Large lump near nipple
  • Growth of papillary cell into a lumen
Ultrasound:
  • Well-defined
  • Solid nodule
Lipoma
  • Common between age of 40-60 years old
  • Benign tumors
  • May experience recurrence
+
  • Solitary
  • Mobile
  • Soft mass
Ultrasound:
  • Well-Circumscribed
  • Hypoechoic lesion
Sclerosing adenosis
  • Recurrent pain during mensturation
  • May present as a mass or incidental finding on mammogram
  • No treatment is needed
± +
  • Multiple lesion
  • Firm
  • Tender nodules
±
  • Proliferative disease
Mammography:
Pseudoangiomatous stromal hyperplasia
  • Common in reproductive age women
+
  • Solitary firm mass
  • Thickening
Mammography and ultrasound:
  • Well-defined
  • Solid mass
  • Noncalcified
Mondor's disease
  • Benign and self-limiting disease
  • Resolve after 4-6 weeks
+ +
  • Thick and tender cord on breast skin
+
  • N/A
Ultrasound:
  • Tubular anechoic structure
  • Multiple narrowing areas
Diseases Benign or
Malignant
Demography History Mass Mastalgia Nipple discharge Breast exam Skin changes LAP Histopathology Imaging Gold standard diagnosis
Diabetic mastopathy
  • Suspicious breast mass
  • After diagnosis, excision is not required
+
  • Ill-defined mass
  • Immobile
Ultrasound:
  • Irregular mass
  • Hypoechoic
  • Dense lesion
Gynecomastia
  • Benign breast tissue swelling among men and boys around puberty
+ ± ±
  • Unilateral or bilateral firm mass
  • Breast swelling
  • Rubbery mass
Ultrasound:
Sarcoidosis
  • Rare in patients with systemic involvement
+
  • Firm mass
  • Hard mass
Mammography:
  • Irregular
  • Ill-defined
  • Spiculated solid mass
Fat necrosis + ±
  • Hard or smooth mass
  • Solitary mass
  • Mobile
  • Collections of liquefied fat
Ultrasound:
  • Collections of liquefied fat
  • Oil cysts


External links.


Template:WikiDoc Sources